Walleye Trading’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42M Sell
119,300
-11,100
-9% -$3.96M 0.07% 278
2025
Q4
$42.7M Buy
130,400
+56,300
+76% +$17.9M 0.06% 339
2025
Q3
$20.9M Sell
74,100
-19,600
-21% -$5.68M 0.03% 569
2025
Q2
$26.2M Sell
93,700
-17,000
-15% -$4.82M 0.05% 427
2025
Q1
$34.5M Sell
110,700
-213,400
-66% -$63M 0.08% 263
2024
Q4
$84.5M Buy
324,100
+8,400
+3% +$2.49M 0.18% 98
2024
Q3
$102M Buy
315,700
+57,400
+22% +$18.8M 0.21% 66
2024
Q2
$80.7M Sell
258,300
-59,200
-19% -$17.4M 0.19% 90
2024
Q1
$90.3M Buy
317,500
+55,400
+21% +$16.2M 0.19% 74
2023
Q4
$75.5M Buy
262,100
+155,700
+146% +$42.4M 0.16% 104
2023
Q3
$28.6M Buy
106,400
+24,300
+30% +$6.06M 0.08% 253
2023
Q2
$18.2M Sell
82,100
-63,300
-44% -$14.7M 0.05% 330
2023
Q1
$35.2M Buy
145,400
+79,400
+120% +$19.5M 0.08% 218
2022
Q4
$17.3M Sell
66,000
-164,200
-71% -$44M 0.05% 416
2022
Q3
$51.9M Buy
230,200
+74,000
+47% +$17.9M 0.16% 91
2022
Q2
$38M Buy
156,200
+41,800
+37% +$10.2M 0.12% 139
2022
Q1
$27.7M Buy
114,400
+99,100
+648% +$22.8M 0.09% 250
2021
Q4
$3.44M Buy
15,300
+7,400
+94% +$1.56M 0.01% 1231
2021
Q3
$1.68M Sell
7,900
-11,600
-59% -$2.67M 0.01% 1753
2021
Q2
$4.75M Buy
19,500
+6,800
+54% +$1.67M 0.02% 822
2021
Q1
$3.16M Sell
12,700
-16,600
-57% -$3.96M 0.01% 970
2020
Q4
$6.74M Sell
29,300
-9,600
-25% -$2.21M 0.03% 570
2020
Q3
$9.89M Sell
38,900
-4,100
-10% -$1.02M 0.05% 291
2020
Q2
$10.1M Sell
43,000
-40,800
-49% -$9.31M 0.07% 270
2020
Q1
$17M Sell
83,800
-45,100
-35% -$9.85M 0.13% 86
2019
Q4
$31.1M Buy
128,900
+93,100
+260% +$20.5M 0.21% 70
2019
Q3
$6.93M Buy
35,800
+4,800
+15% +$921K 0.06% 325
2019
Q2
$5.71M Buy
31,000
+1,400
+5% +$251K 0.05% 383
2019
Q1
$5.62M Sell
29,600
-11,200
-27% -$2.14M 0.04% 447
2018
Q4
$7.94M Sell
40,800
-44,400
-52% -$8.66M 0.06% 287
2018
Q3
$17.7M Buy
85,200
+38,600
+83% +$7.61M 0.09% 175
2018
Q2
$8.6M Buy
46,600
+33,000
+243% +$5.84M 0.05% 342
2018
Q1
$2.32M Sell
13,600
-4,100
-23% -$753K 0.01% 1084
2017
Q4
$3.08K Sell
17,700
-400
-2% -$70.8K 0.02% 985
2017
Q3
$3.38K Sell
18,100
-1,700
-9% -$301K 0.02% 914
2017
Q2
$3.41K Sell
19,800
-28,800
-59% -$4.68M 0.02% 823
2017
Q1
$7.97K Buy
48,600
+32,900
+210% +$5.47M 0.06% 289
2016
Q4
$2.3M Sell
15,700
-18,600
-54% -$2.8M 0.02% 873
2016
Q3
$5.72M Sell
34,300
-20,200
-37% -$3.42M 0.04% 371
2016
Q2
$8.29M Buy
54,500
+8,700
+19% +$1.35M 0.05% 255
2016
Q1
$6.87M Sell
45,800
-142,200
-76% -$21.1M 0.06% 295
2015
Q4
$30.5M Buy
188,000
+162,000
+623% +$25.5M 0.3% 42
2015
Q3
$3.59M Sell
26,000
-63,900
-71% -$10.1M 0.03% 412
2015
Q2
$13.8M Buy
89,900
+78,100
+662% +$12.5M 0.14% 108
2015
Q1
$1.89M Buy
11,800
+7,700
+188% +$1.21M 0.02% 666
2014
Q4
$653K Buy
4,100
+3,000
+273% +$467K 0.01% 1349
2014
Q3
$154K Sell
1,100
-4,500
-80% -$588K ﹤0.01% 2293
2014
Q2
$663 Sell
5,600
-14,800
-73% -$1.71M 0.01% 1062
2014
Q1
$2.52K Buy
20,400
+11,200
+122% +$1.36M 0.04% 352
2013
Q4
$1.05M Sell
9,200
-9,200
-50% -$1.05M 0.01% 1060
2013
Q3
$2.06M Sell
18,400
-35,800
-66% -$3.88M 0.02% 537
2013
Q2
$5.35M Buy
+54,200
New +$5.62M 0.05% 292

Other funds holding AMGN

Walleye Trading's AMGN Position: Q1 2026 in Review

Walleye Trading held its Amgen (AMGN) position steady in Q1 2026 at 200 shares worth $70.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3585.

Walleye Trading first reported a position in AMGN in Q3 2013 and has held it in 29 quarters since. The position peaked at $25.4M in Q4 2022. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Walleye Trading held 200 shares of Amgen worth $70.4K as of Q1 2026.
  • Walleye Trading left its Amgen share count unchanged in Q1 2026.
  • Amgen made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3585 holding.
  • Walleye Trading first reported a position in Amgen in Q3 2013 and has held it in 29 quarters since.
  • Walleye Trading's Amgen position peaked at $25.4M in Q4 2022.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.